BAY12-8039

· Bayer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BAY12-8039, covering 2009-12-02 to 2010-01-11. Get the full timeline:

Most recent: Clinical Trial Update: BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia [Phase 3]